REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 39 filers reported holding REPARE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,664,000 | -73.0% | 800,000 | -52.9% | 1.29% | -65.1% |
| Q4 2021 | $35,853,000 | +6729.1% | 1,700,000 | +8400.0% | 3.70% | +9631.6% |
| Q3 2021 | $525,000 | -94.9% | 20,000 | -93.9% | 0.04% | -95.6% |
| Q2 2021 | $10,289,000 | -62.7% | 330,000 | -63.3% | 0.86% | -67.9% |
| Q1 2021 | $27,621,000 | +19.0% | 900,000 | +33.0% | 2.70% | +35.5% |
| Q4 2020 | $23,217,000 | -22.8% | 676,894 | -30.7% | 1.99% | -48.3% |
| Q3 2020 | $30,059,000 | +48.1% | 976,894 | +46.5% | 3.85% | -5.1% |
| Q2 2020 | $20,293,000 | – | 666,894 | – | 4.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,532,150 | $86,853,000 | 24.47% |
| MPM ASSET MANAGEMENT LLC | 3,003,772 | $103,029,000 | 14.58% |
| MPM BioImpact LLC | 4,776,674 | $163,840,000 | 14.15% |
| BVF INC/IL | 2,972,191 | $101,946,000 | 4.01% |
| Logos Global Management LP | 676,894 | $23,217,000 | 1.99% |
| Redmile Group, LLC | 2,647,696 | $90,816,000 | 1.10% |
| Orbimed Advisors | 3,426,325 | $117,523,000 | 1.03% |
| CLOUGH CAPITAL PARTNERS L P | 280,979 | $9,638,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 224,300 | $7,693,000 | 0.68% |
| Artal Group S.A. | 570,000 | $19,551,000 | 0.42% |